The change has led to timed drills at hospitals to prepare for the new storage requirements, and healthcare professionals expressed concern that the delay could delay access to critical treatments. Pharmacists told the Post there will be more calls back and forth between busy physicians’ offices, and all pharmacies will have to report “eligible prescription transactions” to the state’s Prescription Monitoring Program.
The law, unprecedented in the U.S., places mifepristone and misoprostol alongside opioids and other controlled substances.
The legislation is a part of a broader push to restrict abortion access in Louisiana, the report said.
